Trevena Inc (TRVN): TRVN The Company also reaffirmed THE exp...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Trevena Inc (TRVN)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	4053
Posts	151254
Boards Moderated	4
Alias Born	08/05/2009

Re: Golden Cross post# 1267

Wednesday, 05/31/2023 7:20:57 AM

Wednesday, May 31, 2023 7:20:57 AM

TRVN The Company also reaffirmed THE expected timing of its many near-term milestones:

TRV045 Target Engagement Study. Topline data from the clinical proof-of-concept study, expected 3Q 2023

TRV045 Transcranial Magnetic Stimulation (TMS) Study. Topline data from the clinical proof-of-concept study, expected 3Q 2023

OLINVYK New Respiratory Data and Additional Health Utilization and Cost Analyses. Data and analyses from ~200 patient real-world clinical outcomes study, expected mid-2023

$3M Nhwa Milestone. Receipt of $3 million milestone payment for OLINVYK regulatory approval in China from Jiangsu Nhwa Pharmaceuticals (Nhwa), expected 2Q 2023

$15M R-Bridge Tranche. $15 million non-dilutive financing tranche from R-Bridge upon first commercial sale of OLINVYK in China, which Nhwa expects 3Q 2023

Always consult an Investment Professional, my posts are my own opinions, and not for investing decisions

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent TRVN News

Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:00:24 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/20/2024 09:06:01 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:34:30 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/09/2024 09:05:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 12:05:28 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/23/2024 09:15:32 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/23/2024 05:15:19 AM
Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/19/2024 09:30:30 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/10/2024 09:30:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:01:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 07:09:21 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:57:47 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:57:32 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:57:10 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:56:52 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:56:10 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 10:51:37 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 10:50:51 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 10:50:07 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 10:49:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 10:47:39 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/01/2023 10:12:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:21:03 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 11:05:20 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2023 09:26:45 PM

More TRVN News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow